AstraZeneca Beats Investor Suit Over Covid-19 Vaccine Testing

AstraZeneca plc won the dismissal of a would-be class action brought by investors who accused the drug-maker of misleading them about its Covid-19 vaccine testing process.

Investors didn’t identify any misleading statements AstraZeneca made about clinical trials of the vaccine, which was developed with Oxford University, Judge J. Paul Oetken in the U.S. District Court for the Southern District of New York said Monday.

“Rather, in boilerplate fashion, the amended complaint identifies statements throughout the class period, italicizes them within long block quotes, and then, after each one, repeats a copy-and-pasted list of omissions,” Oetken said.

Oetken also said ...